| A Study to Evaluate the Effectiveness and Safety of a Fixed Dose Combination of Azilsartan Medoxomil and Chlorthalidone in Patients With High Blood Pressure Who do Not Achieve Target Blood Pressure Following Treatment With Azilsartan Medoxomil Alone (NCT01456169) | Takeda | 2011-10-01 |
| Renal Sympathetic Modification in Patients With Essential Hypertension (NCT01417221) | The Second Affiliated Hospital of Chongqing Medical University | 2011-08-01 |
| Antihypertensive Effect of Rostafuroxin Compared With Losartan in Hypertensive Patients Bearing Specified Gene Mutations (NCT01320397) | RostaQuo S.p.A. | 2011-05-01 |
| Resistant Arterial Hypertension Cohort Study (NCT01083017) | University Hospital, Geneva | 2011-04-01 |
| The Prevalence of Sympathetic Overactivity in Primary Hypertensive Patients. (NCT01295021) | AstraZeneca | 2011-02-01 |
| Long Term Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension (NCT01237873) | Novartis Pharmaceuticals | 2011-01-01 |
| Vascular Impact of Omega-3 in Metabolic Syndrome (NCT01566188) | University Hospital, Rouen | 2011-01-01 |
| Clinical Trial to Evaluate the Antihypertensive Effect of AGSCT101 in Patient With Hypertension (NCT01413048) | Ahn-Gook Pharmaceuticals Co.,Ltd | 2011-01-01 |
| Intensive Vasodilator Therapy in Patients With Essential Hypertension (NCT01180413) | Aarhus University Hospital | 2010-12-01 |
| A Clinical Study to Evaluate Efficacy and Safety of Fimasartan/Hydrochlorothiazide Combination-therapy (NCT01258673) | Boryung Pharmaceutical Co., Ltd | 2010-11-01 |
| A Long-term (12 Months) Safety, Tolerability and Efficacy Study of LCZ696 in Patients With Essential Hypertension (NCT01256411) | Novartis Pharmaceuticals | 2010-11-01 |
| Canrenone as Add-on in Patients With Essential Hypertension (NCT02687178) | University of Pavia | 2010-10-01 |
| Efficacy and Safety of SPA100 (Fixed-dose Combination of Aliskiren/Amlodipine) in Patients With Essential Hypertension (NCT01237223) | Novartis | 2010-10-01 |
| Pharmacokinetic Drug Interactions Between Single and Concomitant Administrations of Amlodipine, Losartan, and Hydrochlorothiazide in Subjects With (Pre)Hypertension (NCT01198249) | Yonsei University | 2010-09-01 |
| The Effects of Amiloride and Spironolactone on Renophysiological and Cardiovascular Variables (NCT01195805) | Regional Hospital Holstebro | 2010-08-01 |
| The Confirmatory Olmesartan Plaque Regression Study (NCT01132768) | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 2010-05-01 |
| A Clinical Trial to Compare and Evaluate the Pharmacokinetic Characteristics and the Safety of Fimasartan in Hepatic Impairment Patients and Healthy Volunteers (NCT01146938) | Boryung Pharmaceutical Co., Ltd | 2010-05-01 |
| Aliskiren in Combination With Amlodipine in Hypertensive Patients Not Responding to Angiotensin Receptor Blocker (ARB) Plus Amlodipine (NCT01113047) | Novartis | 2010-05-01 |
| Hybrid Blood Pressure Monitor Validation (NCT01120990) | University of Athens | 2010-04-01 |
| Effectiveness and Patient Self-assessed Compliance of Blood Pressure Treatment With Tarka® Fixed Combination in Patients With Essential Hypertension (NCT01127139) | Abbott | 2010-04-01 |
| Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension (NCT01093807) | RECORDATI GROUP | 2010-03-01 |
| Inflammatory Response to Salt in Essential Hypertension (NCT01665534) | Carmine Zoccali | 2010-03-01 |
| Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochlorothiazide in Participants With Moderate to Severe Hypertension. (NCT01033071) | Takeda | 2010-01-01 |
| Monotherapy Versus Dual Therapy for Initial Treatment for Hypertension (NCT00994617) | University of Cambridge | 2010-01-01 |
| Efficacy and Safety of Levamlodipine Besylate Compared to Amlodipine Maleate in Patients With Essential Hypertension (NCT01131546) | Jiangsu Simcere Pharmaceutical Co., Ltd. | 2009-12-01 |
| Efficacy and Safety of Lercanidipine and Valsartan in Patients With Essential Hypertension (NCT01122251) | LG Life Sciences | 2009-12-01 |
| Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients (NCT01042392) | Novartis | 2009-11-01 |
| Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension (NCT00996281) | Takeda | 2009-10-01 |
| Efficacy and Safety of Valsartan/Amlodipine in Patients With Mild to Moderate Essential Hypertension (NCT01001572) | Novartis | 2009-09-01 |
| A Clinical Trial to Evaluate the Effect of Fimarsartan on Pharmacodynamics, Pharmacokinetics, and the Safety of Warfarin in Healthy Male Volunteers (NCT00938132) | Boryung Pharmaceutical Co., Ltd | 2009-07-01 |
| A Study to Evaluate the Effect of Atorvastatin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers (NCT00991705) | Boryung Pharmaceutical Co., Ltd | 2009-07-01 |
| Parallel-Group Comparison of Olmesartan (OLM), Amlodipine (AML) and Hydrochlorothiazid (HCTZ) in Hypertension (NCT00923091) | Daiichi Sankyo | 2009-06-01 |
| A Study to Evaluate the Pharmacokinetic Drug Interaction After Oral Concurrent Administration of Fimasartan and Amlodipine in Healthy Male Volunteers (NCT00938197) | Boryung Pharmaceutical Co., Ltd | 2009-06-01 |
| A Study to Evaluate the Effect of Ketoconazole and Rifampicin on the Pharmacokinetics of Fimasartan in Healthy Male Volunteers (NCT00938262) | Boryung Pharmaceutical Co., Ltd | 2009-04-01 |
| Hydrochlorothiazide as add-on to Olmesartan/Amlodipine in Hypertension (NCT00902538) | Daiichi Sankyo | 2009-04-01 |
| Efficacy and Safety of Azilsartan Medoxomil Plus Chlorthalidone in Participants With Moderate to Severe Hypertension (NCT00846365) | Takeda | 2009-03-01 |
| A Study to Evaluate the Safety and Pharmacokinetics After Oral Concurrent Administration of Fimasartan and Hydrochlorothiazide in Healthy Male Volunteers (NCT00923533) | Boryung Pharmaceutical Co., Ltd | 2009-03-01 |
| Efficacy and Safety of Azilsartan Medoxomil and Chlorthalidone in Participants With Moderate to Severe Hypertension (NCT00818883) | Takeda | 2009-02-01 |
| Home Blood Pressure in Hypertension Management (NCT00841308) | University of Athens | 2009-02-01 |
| Study to Compare and Assess the Safety and Pharmacokinetic Characteristics After Oral Administration of Fimasartan (BR-A-657∙K) in Healthy Elderly and Young Male Volunteers (NCT00937534) | Boryung Pharmaceutical Co., Ltd | 2009-01-01 |
| A Therapeutic Exploratory Clinical Study to Evaluate the Antihypertensive Efficacy of Fimasartan (BR-A-657•K) During 24 Hours in Patients With Mild to Moderate Essential Hypertension (NCT00922441) | Boryung Pharmaceutical Co., Ltd | 2008-12-01 |
| Specificity of Elevated Plasma EM66 Levels in Pheochromocytoma (NCT01022515) | University Hospital, Rouen | 2008-11-01 |
| In-practice Evaluation of Atacand 16mg Antihypertensive Effect (NCT00802542) | AstraZeneca | 2008-11-01 |
| A Study to Evaluate Efficacy and Safety of LCI699 in Participants With Essential Hypertension (NCT00758524) | Novartis Pharmaceuticals | 2008-09-11 |
| Prognostic Value of the Circadian Pattern of Ambulatory Blood Pressure for Multiple Risk Assessment (NCT00741585) | University of Vigo | 2008-09-01 |
| Valsartan and Amlodipine Compared to Losartan and Amlodipine in Hypertensive Patients (NCT00716950) | University of Pavia | 2008-07-01 |
| A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension (NCT00667719) | Novartis | 2008-06-05 |
| Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular (NCT00659451) | University of Pavia | 2008-04-01 |
| Efficacy and Safety of Once Daily Dosing of Aliskiren (300 mg (qd) Once a Day) to Twice Daily Dosing of Aliskiren (150 mg (Bid) Twice a Day) in Treating Moderate Hypertension. (NCT00654875) | Novartis | 2008-03-01 |
| Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension (NCT00644475) | University of Pavia | 2008-03-01 |
| Efficacy and Safety of Weak Extremely Low Frequency Electromagnetic Fields in Mild and Moderate Essential Hypertension (NCT00709930) | Kyoto University | 2007-12-01 |
| Clinical Trial to Evaluate the Efficacy and the Safety of Antihypertensive Tablets (NCT00553865) | Jeil Pharmaceutical Co., Ltd. | 2007-11-01 |
| Effects of Angiotensin II Receptor Blocker Compared With Diuretics in High-risk Hypertensive Patients (NCT01011660) | Chinese Academy of Medical Sciences, Fuwai Hospital | 2007-10-01 |
| Evaluation of Effect of Combination With Telmisartan and Hydrochlorothiazide in Hypertensives Uncontrolled on Amlodipine (NCT00509470) | Tokyo University | 2007-07-01 |
| Efficacy and Safety of Azilsartan in Participants With Mild to Moderate Uncomplicated Essential Hypertension (NCT01289132) | Takeda | 2007-07-01 |
| Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fed Conditions (NCT01013155) | Roxane Laboratories | 2007-05-01 |
| Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fasted Conditions (NCT01012687) | Roxane Laboratories | 2007-04-01 |
| Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension (NCT00430950) | Daiichi Sankyo | 2007-02-01 |
| Use of the Combination of Olmesartan and Hydrochlorothiazide in Essential Hypertension (NCT00430508) | Daiichi Sankyo | 2007-02-01 |
| Effectiveness of Eplerenone to Improve Target Organ Damage in Patients With Resistant Arterial Hypertension (NCT00138944) | University of Erlangen-Nürnberg Medical School | 2007-01-01 |
| The Effect of Eprosartan on Hormones and Kidney Function in Patients With Essential Hypertension (NCT00438945) | Regional Hospital Holstebro | 2007-01-01 |
| Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension (NCT00437645) | Novartis Pharmaceuticals | 2007-01-01 |
| Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/Hydrochlorothiazide (NCT00608153) | AstraZeneca | 2007-01-01 |
| Candesartan and Candesartan/ Hydrochlorothiazide in the Treatment of Patients With Hypertension and LVH (NCT00607633) | AstraZeneca | 2007-01-01 |
| Pharmacosurveillance and Pharmacogenetics of First-line Diuretics in Hypertension: The StayOnDiur Study (NCT00408512) | Federico II University | 2006-12-01 |
| Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension (NCT00425373) | Novartis Pharmaceuticals | 2006-11-01 |
| Early Metabolic Changes With Thiazide or Beta Blocker Therapy for Essential Hypertension (NCT00380289) | University of Cambridge | 2006-09-01 |
| Efficacy and Safety of Olmesartan Medoxomil in Stage 1 and 2 Essential Hypertension (NCT00890591) | Daiichi Sankyo | 2006-08-01 |
| Evaluation of the Additional Efficacy, and Safety of Olmesartan Medoxomil 20mg / Hydrochlorothiazide 12.5mg in the Treatment of Chinese Patients With Mild to Moderate Essential Hypertension (NCT00872586) | Daiichi Sankyo | 2006-08-01 |
| The Effect of Metformin on the Correlation Between Hyperinsulinemia and Hypertension (NCT01342614) | China-Japan Friendship Hospital | 2006-05-01 |
| Loaded Breathing Training in Essential Hypertension (NCT00791986) | Khon Kaen University | 2006-05-01 |
| Efficacy and Safety of Aliskiren 300mg Compared to Irbesartan 300mg and Ramipril 10 mg in the Setting of a Missed Dose for Patients With Essential Hypertension. (NCT00343551) | Novartis | 2006-05-01 |
| Olmesartan and an add-on Treatment in Patients With Mild to Moderate Hypertension (NCT00311155) | Sankyo Pharma Gmbh | 2006-03-01 |
| A Study to Evaluate the Efficacy of Valsartan/Simvastatin Combinations in Patients With Both Essential Hypertension and Hypercholesterolemia (NCT00254475) | Novartis | 2005-11-01 |
| Efficacy, Safety and Pharmacodynamic/Pharmacokinetic Study of Fimasartan (BR-A-657•K) (NCT00937651) | Boryung Pharmaceutical Co., Ltd | 2005-04-01 |
| Olmesartan as an add-on to Amlodipine in Hypertension (NCT00220233) | Sankyo Pharma Gmbh | 2005-04-01 |
| Amlodipine as add-on to Olmesartan in Hypertension (NCT00220220) | Sankyo Pharma Gmbh | 2005-04-01 |
| Hydrochlorothiazide (+) Losartan Potassium vs. Amlodipine Comparative Study (0954A-314) (NCT00157963) | Organon and Co | 2005-02-05 |
| Efficacy of Rostafuroxin in the Treatment of Essential Hypertension (NCT00415038) | sigma-tau i.f.r. S.p.A. | 2005-02-01 |
| Safety, Tolerability, Pharmacodynamic Effects and Preliminary Evidence for Efficacy of the Anti-Hypertension Vaccine CYT006-AngQb (NCT00500786) | Cytos Biotechnology AG | 2004-11-01 |
| Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea (NCT00328965) | GlaxoSmithKline | 2004-11-01 |
| Uric Acid in Essential Hypertension in Children (NCT00288184) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2004-09-01 |
| Olmesartan Medoxomil Versus Losartan Potassium in Patients With Mild to Moderate Essential Hypertension (NCT00856271) | Daiichi Sankyo | 2004-08-01 |
| Autonomic Imbalance and 24-h Blood Pressure Change in Patients With Chronic Renal Disease (NCT00298129) | Yokohama City University Medical Center | 2004-02-01 |
| Doxazosin Effects on ABPM in Hypertensive Patients With Diabetic Nephropathy (NCT00295555) | Yokohama City University Medical Center | 2004-01-01 |
| Fimasartan (BR-A-657) Multiple Oral Dose in Healthy Subjects (NCT01289899) | Boryung Pharmaceutical Co., Ltd | 2004-01-01 |
| Fimasartan (BR-A-657) Single Oral Dose in Healthy Subjects (NCT01289886) | Boryung Pharmaceutical Co., Ltd | 2003-09-01 |
| Olmesartan Medoxomil in Hypertension and Renal Impairment (NCT00151827) | Sankyo Pharma Gmbh | 2003-08-01 |
| Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly (NCT00751751) | Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company | 2003-06-01 |
| Motivational Interviewing (NCT00208104) | Columbia University | 2002-07-01 |
| Olmesartan Medoxomil Versus Losartan in Patients With Hypertension (NCT00857285) | Daiichi Sankyo | 2002-05-01 |
| Olmesartan in Essential Hypertension (NCT00185172) | Sankyo Pharma Gmbh | 2002-01-01 |
| Olmesartan Medoxomil in Atherosclerosis (NCT00185185) | Sankyo Pharma Gmbh | 2001-11-01 |
| Hypertension: Prediction of Biofeedback Success (NCT00026065) | National Center for Complementary and Integrative Health (NCCIH) | 2000-02-01 |
| Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension (NCT06395194) | Oslo University Hospital | 1997-09-27 |
| Heart Rate Variability in White Coat Hypertension and Essential Hypertension (NCT00286884) | Regional Hospital Holstebro | |